Send us a Text Message.1.7 mg of Wegovy is no longer in shortage:Semaglutide: FDA website updated to show 1.7 mg of Wegovy is no longer in shortageLink: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20Injection&st=cGNC introduces special section for GLP-1 users:GNC will have special section for GLP-1 users that will concentrate on four areas: GI Health, Retaining Lean muscle mass, Bone health, Nutritional supportLink: https://www.gnc.com/learn/newsroom/gnc-semaglutide-support-program.htmlIdentified upper dose values in tirzepatide high-dose trial20 mg and 25 mgPrimary Completion in this trial is 12/24/2024 (Merry Christmas) with final completion September 30, 2025 Link:  https://www.onthepen.com/post/higher-doses-of-zepbound-and-mounjaro-being-testedUS Senator Bernie Sanders investigating the price of Wegovy/OzempicOzempic costs $936 per month, while Wegovy costs $1,350Ozempic costs $155 in Canada, and cost $59 in Germany. This dramatic difference in cost has led to concerns about the accessibility and affordability of these drugs for American patients.With the cardiovascular disease indication, millions of additional medicare patients are eligible for taking Wegovy which means billions at the current prices Link:  https://www.onthepen.com/post/the-price-of-health-bernie-sanders-investigates-ozempic-and-wegovyLink: https://www.kff.org/medicare/issue-brief/a-new-use-for-wegovy-opens-the-door-to-medicare-coverage-for-millions-of-people-with-obesity/Germany is promoting their pharmaceuticals industry: tax breaks, and speeding up clinical trialsEli Lilly is investing 2.3 Billion Euros to build a glp-1 manufacturing plant in Germany:Link: https://uk.finance.yahoo.com/news/scholz-promises-support-pharma-sector-101833297.htmlLexaria begins phase 1 trial:Lexaria (stock symbol: LEXX) will test their technology to improve stomach absorption of Rybelsus in phase 1 trial (i.e. wouldn't need large 25/50 mg doses if absorption was better). They are also testing under tongue (sublingual) absorption of Rybelsus in another phase 1 trialLink: https://ir.lexariabioscience.com/news-events/press-releases/detail/246/lexaria-receives-ethics-review-board-approval-to-begin-newViking Therapeutics earnings callPlanning to start addition phase 2 trial of injectable VikingTide (VK2735) in Q4 of 2024 that will last 6-9 months (If you remember, the first phase 2 trial was only 13 weeks)The oral VikingTide (VK2735) phase 1 trial is still investigating higher and higher  doses due to the low side effect profile. They expect results in summer of 2024.MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinVenmo: OnThePenCa$h App: ManOnMounjaroSOCIAL LINKShttps://www.tiktok.com/@manonthemounjarohttps://twitter.com/ManOnMounjarohttps://instagram.com/manonthemounjarohttps://facebook.com/manonthemounjaroThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!